FDA Dental Products Advisory Panel
This article was originally published in The Gray Sheet
Executive Summary
Scheduled to meet Dec. 5-7 at the Renaissance Hotel in Washington, D.C. The first day of the meeting will cover dental device ingredient labeling and a draft guidance on temporomandibular joint implants. On Dec. 6, the panel's plaque subcommittee is slated to discuss OTC anti-plaque products, while the Dec. 7 agenda calls for discussion of guidance documents for endosseous implants and dental handpieces. For information, call Jeanne Rippere or Stephanie Mason at 301/594-1003